CCN2 and pancreatic neoplasm: Indeed, CTGF/CCN2 expression and secretion was increased in hypoxic pancreatic tumor cells in vitro, and co-localized with hypoxia in pancreatic tumor xenografts and clinical pancreatic adenocarcinomas (Bennewith et al., 2009).